Director Milton C. Blackmore of Innospec Inc. (IOSP) disclosed multiple equity transactions recorded in filings with the Securities and Exchange Commission.
On February 20, Blackmore sold 1,030 shares of Innospec common stock at $81.84 per share, a transaction that totaled $84,296. The sale was reported while the stock was trading at $79.30, a price that represents a decline of nearly 8% over the prior week.
The same Form 4 filing shows Blackmore exercised stock options on February 20 to acquire 1,030 shares at an option price of $44.18, for a reported total value of $45,505. A few days later, on February 23, he recorded the acquisition of 1,539 restricted stock units, for which the filing lists a value of $0.00.
After completing these transactions, Blackmore is shown as directly owning 11,124 shares of Innospec common stock.
Company snapshot cited in filings
- The specialty chemicals company is described as having a market value of $1.96 billion.
- InvestingPro analysis referenced in the filing indicates the company trades at a price-to-earnings ratio of 17.
- The firm has increased its dividend for 12 consecutive years and currently offers a 2.19% yield, per the same analysis.
- InvestingPro is noted as providing access to more than 10 additional tips for IOSP investors.
Context and implications
The documents show a mix of selling, option exercise, and restricted unit grants in a short time window in February. The reported sale and the contemporaneous option exercise are disclosed alongside a share-price move that left the security trading below the sale price and down almost 8% over the prior week. The filings also include a note on the valuation and dividend record cited from InvestingPro.
Where the filings list a value of $0.00 for the restricted stock units, the filing itself provides that figure without additional explanatory detail.